NOD-like Receptors—Emerging Links to Obesity and Associated Morbidities
暂无分享,去创建一个
[1] P. Rosenstiel,et al. NLRC5 affects diet-induced adiposity in female mice and co-regulates peroxisome proliferator-activated receptor PPARγ target genes , 2023, iScience.
[2] J. Schertzer,et al. Postbiotics engage IRF4 in adipocytes to promote sex‐dependent changes in blood glucose during obesity , 2022, Physiological reports.
[3] S. Choi,et al. Adipocyte differentiation between obese and lean conditions depends on changes in miRNA expression , 2022, Scientific Reports.
[4] Xin Wang,et al. Programmed cell death in atherosclerosis and vascular calcification , 2022, Cell Death & Disease.
[5] A. Adem,et al. Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives , 2022, Biomolecules.
[6] Jianing Fu,et al. Structural Mechanisms of NLRP3 Inflammasome Assembly and Activation. , 2022, Annual review of immunology.
[7] A. Tamrakar,et al. Insulin resistance corresponds with a progressive increase in NOD1 in high fat diet-fed mice , 2022, Endocrine.
[8] S. Ramanathan,et al. NLRC5 Deficiency Deregulates Hepatic Inflammatory Response but Does Not Aggravate Carbon Tetrachloride-Induced Liver Fibrosis , 2021, Frontiers in Immunology.
[9] Seong-eun Park,et al. Gut Microbiome and Metabolome Profiles Associated with High-Fat Diet in Mice , 2021, Metabolites.
[10] Matthew S. Miller,et al. Gut microbiota-based vaccination engages innate immunity to improve blood glucose control in obese mice , 2021, bioRxiv.
[11] J. Eilers,et al. Adipocyte death triggers a pro-inflammatory response and induces metabolic activation of resident macrophages , 2021, Cell Death & Disease.
[12] M. Schröder,et al. DDX3X Links NLRP11 to the Regulation of Type I Interferon Responses and NLRP3 Inflammasome Activation , 2021, Frontiers in Immunology.
[13] S. Ramanathan,et al. The MHC Class-I Transactivator NLRC5: Implications to Cancer Immunology and Potential Applications to Cancer Immunotherapy , 2021, International journal of molecular sciences.
[14] A. Orekhov,et al. Overview of OxLDL and Its Impact on Cardiovascular Health: Focus on Atherosclerosis , 2021, Frontiers in Pharmacology.
[15] I. Sjaastad,et al. NLRP3 inflammasome deficiency attenuates metabolic disturbances involving alterations in the gut microbial profile in mice exposed to high fat diet , 2020, Scientific Reports.
[16] R. Dziarski,et al. Nod2 protects mice from inflammation and obesity-dependent liver cancer , 2020, Scientific Reports.
[17] T. Kanneganti,et al. NLRP12 in innate immunity and inflammation. , 2020, Molecular aspects of medicine.
[18] J. Gagnon,et al. The Role of the Bacterial Muramyl Dipeptide in the Regulation of GLP-1 and Glycemia , 2020, International journal of molecular sciences.
[19] L. Boscá,et al. NOD1 deficiency promotes an imbalance of thyroid hormones and microbiota homeostasis in mice fed high fat diet , 2020, Scientific Reports.
[20] N. Câmara,et al. NOD2 Deficiency Promotes Intestinal CD4+ T Lymphocyte Imbalance, Metainflammation, and Aggravates Type 2 Diabetes in Murine Model , 2020, Frontiers in Immunology.
[21] K. Foley,et al. NOD2 in hepatocytes engages a liver-gut axis to protect against steatosis, fibrosis, and gut dysbiosis during fatty liver disease in mice. , 2020, American journal of physiology. Endocrinology and metabolism.
[22] K. Foley,et al. Postbiotics for NOD2 require non-hematopoietic RIPK2 to improve blood glucose and metabolic inflammation in mice. , 2020, American journal of physiology. Endocrinology and metabolism.
[23] Liliang Jin,et al. The NLRP6 inflammasome in health and disease , 2020, Mucosal Immunology.
[24] G. Frühbeck,et al. NLRP3 inflammasome blockade reduces adipose tissue inflammation and extracellular matrix remodeling , 2019, Cellular & Molecular Immunology.
[25] M. Nieuwdorp,et al. Oral vancomycin treatment does not alter markers of postprandial inflammation in lean and obese subjects , 2019, Physiological reports.
[26] I. Sjaastad,et al. NLRP3 Inflammasome Promotes Myocardial Remodeling During Diet-Induced Obesity , 2019, Front. Immunol..
[27] Dali Li,et al. NLRC5 inhibits neointima formation following vascular injury and directly interacts with PPARγ , 2019, Nature Communications.
[28] F. Azizi,et al. Identifying new associated pleiotropic SNPs with lipids by simultaneous test of multiple longitudinal traits: An Iranian family-based study. , 2019, Gene.
[29] M. Szyf,et al. Differential genome-wide DNA methylation patterns in childhood obesity , 2019, BMC Research Notes.
[30] Rachel M Olson,et al. Yersinia pestis Exploits Early Activation of MyD88 for Growth in the Lungs during Pneumonic Plague , 2019, Infection and Immunity.
[31] Yingliang Wu,et al. Cholesterol Homeostatic Regulator SCAP‐SREBP2 Integrates NLRP3 Inflammasome Activation and Cholesterol Biosynthetic Signaling in Macrophages , 2018, Immunity.
[32] M. Netea,et al. The Inhibitory Innate Immune Sensor NLRP12 Maintains a Threshold against Obesity by Regulating Gut Microbiota Homeostasis. , 2018, Cell host & microbe.
[33] P. Shridas,et al. High-density lipoprotein inhibits serum amyloid A–mediated reactive oxygen species generation and NLRP3 inflammasome activation , 2018, The Journal of Biological Chemistry.
[34] S. Wueest,et al. The role of adipocyte-specific IL-6-type cytokine signaling in FFA and leptin release , 2018, Adipocyte.
[35] B. Neuschwander‐Tetri,et al. Mechanisms of NAFLD development and therapeutic strategies , 2018, Nature Medicine.
[36] Paul Timpson,et al. Evidence that TLR4 Is Not a Receptor for Saturated Fatty Acids but Mediates Lipid-Induced Inflammation by Reprogramming Macrophage Metabolism. , 2018, Cell metabolism.
[37] A. Bosco,et al. Gain-of-function SNPs in NLRP3 and IL1B genes confer protection against obesity and T2D: undiscovered role of inflammasome genetics in metabolic homeostasis? , 2018, Endocrine.
[38] M. Oosting,et al. Western Diet Triggers NLRP3-Dependent Innate Immune Reprogramming , 2018, Cell.
[39] H. Deng,et al. Identifying potentially common genes between dyslipidemia and osteoporosis using novel analytical approaches , 2018, Molecular Genetics and Genomics.
[40] D. Underhill,et al. Peptidoglycan recognition by the innate immune system , 2018, Nature Reviews Immunology.
[41] Y. Qing,et al. Association of NLRP3 polymorphisms with susceptibility to primary gouty arthritis in a Chinese Han population , 2017, Clinical Rheumatology.
[42] S. Ghavami,et al. Inflammasomes and type 2 diabetes: An updated systematic review. , 2017, Immunology letters.
[43] T. Ding,et al. Dexmedetomidine (DEX) protects against hepatic ischemia/reperfusion (I/R) injury by suppressing inflammation and oxidative stress in NLRC5 deficient mice. , 2017, Biochemical and biophysical research communications.
[44] Q. Su,et al. Activation of NLRP3 Inflammasome by Advanced Glycation End Products Promotes Pancreatic Islet Damage , 2017, Oxidative medicine and cellular longevity.
[45] Hailing Li,et al. NLRC5 deficiency ameliorates diabetic nephropathy through alleviating inflammation , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[46] L. Smeeth,et al. An epigenome-wide association study in whole blood of measures of adiposity among Ghanaians: the RODAM study , 2017, Clinical Epigenetics.
[47] D. Crispim,et al. Current role of the NLRP3 inflammasome on obesity and insulin resistance: A systematic review. , 2017, Metabolism: clinical and experimental.
[48] P. Libby,et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease , 2017, The New England journal of medicine.
[49] Shu-ren Ma,et al. NLRC5 deficiency promotes myocardial damage induced by high fat diet in mice through activating TLR4/NF-κB. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[50] M. Idzko,et al. P2X7 Deficiency Blocks Lesional Inflammasome Activity and Ameliorates Atherosclerosis in Mice , 2017, Circulation.
[51] K. Foley,et al. Tyrosine kinase inhibitors of Ripk2 attenuate bacterial cell wall-mediated lipolysis, inflammation and dysglycemia , 2017, Scientific Reports.
[52] K. Foley,et al. Tyrosine kinase inhibitors of Ripk2 attenuate bacterial cell wall-mediated lipolysis, inflammation and dysglycemia , 2017, Scientific Reports.
[53] P. Rosenstiel,et al. Muramyl Dipeptide-Based Postbiotics Mitigate Obesity-Induced Insulin Resistance via IRF4. , 2017, Cell metabolism.
[54] Xiaoping Ma,et al. Resistin increases the expression of NOD2 in mouse monocytes. , 2017, Experimental and therapeutic medicine.
[55] M. Sack,et al. The role of caloric load and mitochondrial homeostasis in the regulation of the NLRP3 inflammasome , 2017, Cellular and Molecular Life Sciences.
[56] R. Pi,et al. Inhibition of AGEs/RAGE/Rho/ROCK pathway suppresses non-specific neuroinflammation by regulating BV2 microglial M1/M2 polarization through the NF-κB pathway , 2017, Journal of Neuroimmunology.
[57] T. R. Licht,et al. High-fat feeding rather than obesity drives taxonomical and functional changes in the gut microbiota in mice , 2017, Microbiome.
[58] R. Dziarski,et al. Nod2 and Nod2-regulated microbiota protect BALB/c mice from diet-induced obesity and metabolic dysfunction , 2017, Scientific Reports.
[59] Frank Noé,et al. Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation , 2017, Front. Immunol..
[60] M. Glogauer,et al. Circulating NOD1 Activators and Hematopoietic NOD1 Contribute to Metabolic Inflammation and Insulin Resistance. , 2017, Cell reports.
[61] F. Pattou,et al. Postprandial macrophage-derived IL-1β stimulates insulin, and both synergistically promote glucose disposal and inflammation , 2017, Nature Immunology.
[62] C. Zhang,et al. Troxerutin Attenuates Enhancement of Hepatic Gluconeogenesis by Inhibiting NOD Activation-Mediated Inflammation in High-Fat Diet-Treated Mice , 2016, International journal of molecular sciences.
[63] H. Tsutsui,et al. Caspase-1 deficiency promotes high-fat diet-induced adipose tissue inflammation and the development of obesity. , 2016, American Journal of Physiology. Endocrinology and Metabolism.
[64] J. Vendrell,et al. Obesity and Type 2 Diabetes Alters the Immune Properties of Human Adipose Derived Stem Cells , 2016, Stem cells.
[65] L. Pulakat,et al. Loss of Nlrp3 Does Not Protect Mice from Western Diet-Induced Adipose Tissue Inflammation and Glucose Intolerance , 2016, PloS one.
[66] D. Ma,et al. Fish-oil-derived n-3 polyunsaturated fatty acids reduce NLRP3 inflammasome activity and obesity-related inflammatory cross-talk between adipocytes and CD11b(+) macrophages. , 2016, The Journal of nutritional biochemistry.
[67] J. Bertin,et al. The Identification and Pharmacological Characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 Kinase. , 2016, Journal of medicinal chemistry.
[68] P. Eriksson,et al. NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis , 2016, Journal of the American Heart Association.
[69] D. Choubey,et al. Hypoxia primes human normal prostate epithelial cells and cancer cell lines for the NLRP3 and AIM2 inflammasome activation , 2016, Oncotarget.
[70] D. Bobbala,et al. NLRC5 elicits antitumor immunity by enhancing processing and presentation of tumor antigens to CD8+ T lymphocytes , 2016, Oncoimmunology.
[71] Charles C. Kim,et al. Saturated Fatty Acids Engage an IRE1α-Dependent Pathway to Activate the NLRP3 Inflammasome in Myeloid Cells. , 2016, Cell Reports.
[72] Cheng Huang,et al. Role of NLRC5 in progression and reversal of hepatic fibrosis. , 2016, Toxicology and applied pharmacology.
[73] G. Shulman,et al. A Role of the Inflammasome in the Low Storage Capacity of the Abdominal Subcutaneous Adipose Tissue in Obese Adolescents , 2015, Diabetes.
[74] X. Wang,et al. Investigation into the association between NLRP3 gene polymorphisms and susceptibility to type 2 diabetes mellitus. , 2015, Genetics and molecular research : GMR.
[75] Young Keun Kim,et al. NOD-Like Receptors in Infection, Immunity, and Diseases , 2015, Yonsei medical journal.
[76] C. Sasakawa,et al. Molecular mechanisms regulating NLRP3 inflammasome activation , 2015, Cellular and Molecular Immunology.
[77] P. Qu,et al. Expression of the NLRP3 Inflammasome in Carotid Atherosclerosis. , 2015, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[78] T. Wakatsuki,et al. Expression of NLRP3 in subcutaneous adipose tissue is associated with coronary atherosclerosis. , 2015, Atherosclerosis.
[79] T. Cai,et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death , 2015, Nature.
[80] M. Laville,et al. Postprandial Endotoxemia Linked With Chylomicrons and Lipopolysaccharides Handling in Obese Versus Lean Men: A Lipid Dose-Effect Trial. , 2015, The Journal of clinical endocrinology and metabolism.
[81] Yi-jun Zhou,et al. Increased NOD1, but not NOD2, activity in subcutaneous adipose tissue from patients with metabolic syndrome , 2015, Obesity.
[82] J. Nicoli,et al. A Role for Gut Microbiota and the Metabolite‐Sensing Receptor GPR43 in a Murine Model of Gout , 2015, Arthritis & rheumatology.
[83] M. Netea,et al. Bone marrow‐specific caspase‐1/11 deficiency inhibits atherosclerosis development in Ldlr−/− mice , 2015, The FEBS journal.
[84] K. Fritsche. The science of fatty acids and inflammation. , 2015, Advances in nutrition.
[85] M. Haneklaus,et al. NLRP3 at the interface of metabolism and inflammation , 2015, Immunological reviews.
[86] D. Philpott,et al. Regulation of obesity-related insulin resistance with gut anti-inflammatory agents. , 2015, Cell metabolism.
[87] R. Flavell,et al. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome , 2015, Nature Communications.
[88] J. Sandow,et al. A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine production , 2015, Nature Communications.
[89] Gang Wang,et al. P2X7R is involved in the progression of atherosclerosis by promoting NLRP3 inflammasome activation , 2015, International journal of molecular medicine.
[90] J. Ehses,et al. IL-1 mediates amyloid-associated islet dysfunction and inflammation in human islet amyloid polypeptide transgenic mice , 2015, Diabetologia.
[91] N. Paquot,et al. Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease , 2015, Expert opinion on investigational drugs.
[92] M. Surette,et al. Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistance , 2015, EMBO molecular medicine.
[93] Jiangang Chen,et al. Chronic Activation of Pattern Recognition Receptors Suppresses Brown Adipogenesis of Multipotent Mesodermal Stem Cells and Brown Preadipocytes , 2015, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[94] Melissa J. Morine,et al. Monounsaturated Fatty Acid–Enriched High-Fat Diets Impede Adipose NLRP3 Inflammasome–Mediated IL-1β Secretion and Insulin Resistance Despite Obesity , 2015, Diabetes.
[95] S. Legrand-Poels,et al. Free fatty acids as modulators of the NLRP3 inflammasome in obesity/type 2 diabetes. , 2014, Biochemical pharmacology.
[96] Alan D. Lopez,et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2014, The Lancet.
[97] Leif E. Peterson,et al. Transcriptome analysis of human adipocytes implicates the NOD-like receptor pathway in obesity-induced adipose inflammation , 2014, Molecular and Cellular Endocrinology.
[98] S. Legrand-Poels,et al. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. , 2014, Diabetes research and clinical practice.
[99] M. Lappas. NOD1 expression is increased in the adipose tissue of women with gestational diabetes. , 2014, The Journal of endocrinology.
[100] A. Wree,et al. NLRP3 inflammasome activation is required for fibrosis development in NAFLD , 2014, Journal of Molecular Medicine.
[101] Jiangang Chen,et al. Activation of pattern recognition receptors in brown adipocytes induces inflammation and suppresses uncoupling protein 1 expression and mitochondrial respiration. , 2014, American journal of physiology. Cell physiology.
[102] K. Foley,et al. Bacterial Peptidoglycan Stimulates Adipocyte Lipolysis via NOD1 , 2014, PloS one.
[103] A. Tall,et al. Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity. , 2014, Cell metabolism.
[104] D. Philpott,et al. NOD proteins: regulators of inflammation in health and disease , 2013, Nature Reviews Immunology.
[105] Yi-jun Zhou,et al. Saturated fatty acid induces insulin resistance partially through nucleotide-binding oligomerization domain 1 signaling pathway in adipocytes. , 2013, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.
[106] J. Hensen,et al. Impact of interleukin-1β antibody (canakinumab) on glycaemic indicators in patients with type 2 diabetes mellitus: results of secondary endpoints from a randomized, placebo-controlled trial. , 2013, Diabetes & metabolism.
[107] Simon C Watkins,et al. Mitochondrial Reactive Oxygen Species Induces NLRP3-Dependent Lysosomal Damage and Inflammasome Activation , 2013, The Journal of Immunology.
[108] V. Mohan,et al. Convergence of innate immunity and insulin resistance as evidenced by increased nucleotide oligomerization domain (NOD) expression and signaling in monocytes from patients with type 2 diabetes. , 2013, Cytokine.
[109] L. Riva,et al. Unsaturated fatty acids prevent activation of NLRP3 inflammasome in human monocytes/macrophages[S] , 2013, Journal of Lipid Research.
[110] Mao Fu,et al. Variants of NLRP3 gene are associated with insulin resistance in Chinese Han population with type-2 diabetes. , 2013, Gene.
[111] J. Rutledge,et al. Inflammasome-Mediated Secretion of IL-1β in Human Monocytes through TLR2 Activation; Modulation by Dietary Fatty Acids , 2013, The Journal of Immunology.
[112] K. Clément,et al. Fibrosis and adipose tissue dysfunction. , 2013, Cell metabolism.
[113] S. Legrand-Poels,et al. Obesity phenotype is related to NLRP3 inflammasome activity and immunological profile of visceral adipose tissue , 2013, Diabetologia.
[114] Z. Gong,et al. NLRP3 inflammasomes show high expression in aorta of patients with atherosclerosis. , 2013, Heart, lung & circulation.
[115] P. Scherer,et al. Obese adipocytes show ultrastructural features of stressed cells and die of pyroptosis , 2013, Journal of Lipid Research.
[116] M. Czech,et al. Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes , 2013, Nature Medicine.
[117] G. Núñez,et al. K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. , 2013, Immunity.
[118] N. Moustaid‐Moussa,et al. Activation of nucleotide oligomerization domain containing protein 1 induces lipolysis through NF-κB and the lipolytic PKA activation in 3T3-L1 adipocytes. , 2013, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[119] Christine E. Becker,et al. CD36 coordinates NLRP3 inflammasome activation by facilitating the intracellular nucleation from soluble to particulate ligands in sterile inflammation , 2013, Nature Immunology.
[120] Ž. Jakopin. Murabutide revisited: a review of its pleiotropic biological effects. , 2013, Current medicinal chemistry.
[121] W. Rathmann,et al. Acute-Phase Serum Amyloid A Protein and Its Implication in the Development of Type 2 Diabetes in the KORA S4/F4 Study , 2013, Diabetes Care.
[122] D. Philpott,et al. Nod1 and Nod2 signaling does not alter the composition of intestinal bacterial communities at homeostasis , 2013, Gut microbes.
[123] Andrea De Gaetano,et al. Double-Blind, Randomized Study Evaluating the Glycemic and Anti-inflammatory Effects of Subcutaneous LY2189102, a Neutralizing IL-1β Antibody, in Patients With Type 2 Diabetes , 2013, Diabetes Care.
[124] Yikun Yao,et al. Expression regulation and function of NLRC5 , 2013, Protein & Cell.
[125] E. Lien,et al. Inflammasomes and host defenses against bacterial infections. , 2013, Current opinion in microbiology.
[126] P. Libby,et al. Effects of Interleukin-1&bgr; Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen: A Phase IIb Randomized, Placebo-Controlled Trial , 2012, Circulation.
[127] Y. Li,et al. NOD1 activation induces innate immune responses and insulin resistance in human adipocytes. , 2012, Diabetes & metabolism.
[128] V. Tremaroli,et al. Functional interactions between the gut microbiota and host metabolism , 2012, Nature.
[129] A. Capurso,et al. From excess adiposity to insulin resistance: the role of free fatty acids. , 2012, Vascular pharmacology.
[130] K. Krause,et al. Reactive oxygen species: from health to disease. , 2012, Swiss medical weekly.
[131] M. Donath,et al. Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes , 2012, Diabetes Care.
[132] Jiujiu Yu,et al. Critical role for calcium mobilization in activation of the NLRP3 inflammasome , 2012, Proceedings of the National Academy of Sciences.
[133] Jiangang Chen,et al. The effects of NOD activation on adipocyte differentiation , 2012, Obesity.
[134] H. Herfarth,et al. NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling. , 2012, Immunity.
[135] F. Tinahones,et al. Endotoxin increase after fat overload is related to postprandial hypertriglyceridemia in morbidly obese patients , 2012, Journal of Lipid Research.
[136] Yufang Shi,et al. NLRC5 regulates MHC class I antigen presentation in host defense against intracellular pathogens , 2012, Cell Research.
[137] J. Cui,et al. Enhanced TLR-induced NF-κB signaling and type I interferon responses in NLRC5 deficient mice , 2012, Cell Research.
[138] Moshe Arditi,et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. , 2012, Immunity.
[139] J. Gage,et al. Caspase-1 deficiency decreases atherosclerosis in apolipoprotein E-null mice. , 2012, The Canadian journal of cardiology.
[140] A. El-Sohemy,et al. Effects of polymorphisms in nucleotide-binding oligomerization domains 1 and 2 on biomarkers of the metabolic syndrome and type II diabetes , 2012, Genes & Nutrition.
[141] L. Heilbronn,et al. Inflammatory and Oxidative Stress Responses to High-Carbohydrate and High-Fat Meals in Healthy Humans , 2012, Journal of nutrition and metabolism.
[142] N. Al-Daghri,et al. High Fat Intake Leads to Acute Postprandial Exposure to Circulating Endotoxin in Type 2 Diabetic Subjects , 2012, Diabetes Care.
[143] Richard A. Flavell,et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity , 2012, Nature.
[144] A. Tardivel,et al. ER stress activates the NLRP3 inflammasome via an UPR-independent pathway , 2012, Cell Death and Disease.
[145] D. Green,et al. The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis. , 2011, Cancer cell.
[146] A. Klip,et al. Give a NOD to insulin resistance. , 2011, American journal of physiology. Endocrinology and metabolism.
[147] P. Sansonetti,et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment , 2011, EMBO molecular medicine.
[148] L. Joosten,et al. Inflammasome is a central player in the induction of obesity and insulin resistance , 2011, Proceedings of the National Academy of Sciences.
[149] V. Dixit,et al. Elimination of the NLRP3-ASC inflammasome protects against chronic obesity-induced pancreatic damage. , 2011, Endocrinology.
[150] D. Philpott,et al. NOD1 Activators Link Innate Immunity to Insulin Resistance , 2011, Diabetes.
[151] Anna K Rieger,et al. Cutting Edge: Reactive Oxygen Species Inhibitors Block Priming, but Not Activation, of the NLRP3 Inflammasome , 2011, The Journal of Immunology.
[152] J. Bertin,et al. A Functional Role for Nlrp6 in Intestinal Inflammation and Tumorigenesis , 2011, The Journal of Immunology.
[153] Richard A. Flavell,et al. NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis , 2011, Cell.
[154] H. Roche,et al. Lack of Interleukin-1 Receptor I (IL-1RI) Protects Mice From High-Fat Diet–Induced Adipose Tissue Inflammation Coincident With Improved Glucose Homeostasis , 2011, Diabetes.
[155] Denis Gris,et al. Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling , 2011, Nature Immunology.
[156] L. Joosten,et al. Treatment with Anakinra improves disposition index but not insulin sensitivity in nondiabetic subjects with the metabolic syndrome: a randomized, double-blind, placebo-controlled study. , 2011, The Journal of clinical endocrinology and metabolism.
[157] Ling Zhao,et al. NOD1 activation induces proinflammatory gene expression and insulin resistance in 3T3‐L1 adipocytes , 2011, American journal of physiology. Endocrinology and metabolism.
[158] S. Tangye,et al. Inflammatory Mechanisms in Obesity , 2013 .
[159] J. Tschopp,et al. Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome , 2011, Cell Death and Disease.
[160] D. Harats,et al. Reduced atherosclerosis and inflammatory cytokines in apolipoprotein-E-deficient mice lacking bone marrow-derived interleukin-1α. , 2011, Biochemical and biophysical research communications.
[161] Brianne R. Barker,et al. Cutting Edge: NLRC5-Dependent Activation of the Inflammasome , 2011, The Journal of Immunology.
[162] S. Akira,et al. NLRC5 Deficiency Does Not Influence Cytokine Induction by Virus and Bacteria Infections , 2011, The Journal of Immunology.
[163] J. Tschopp,et al. A role for mitochondria in NLRP3 inflammasome activation , 2011, Nature.
[164] S. Ryter,et al. Autophagy proteins regulate innate immune response by inhibiting NALP3 inflammasome-mediated mitochondrial DNA release , 2010, Nature Immunology.
[165] D. Philpott,et al. NOD2 activation induces muscle cell-autonomous innate immune responses and insulin resistance. , 2010, Endocrinology.
[166] E. Ravussin,et al. The NALP3/NLRP3 Inflammasome Instigates Obesity-Induced Autoinflammation and Insulin Resistance , 2010, Nature Medicine.
[167] K. Lauber,et al. Sodium Overload and Water Influx Activate the NALP3 Inflammasome , 2010, The Journal of Biological Chemistry.
[168] T. Billiar,et al. Hepatocytes express functional NOD1 and NOD2 receptors: a role for NOD1 in hepatocyte CC and CXC chemokine production. , 2010, Journal of hepatology.
[169] J. Bournat,et al. Mitochondrial dysfunction in obesity. , 2010, Current opinion in endocrinology, diabetes, and obesity.
[170] Christine E. Becker,et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes , 2010, Nature Immunology.
[171] D. Philpott,et al. NLRC5 Limits the Activation of Inflammatory Pathways , 2010, Journal of Immunology.
[172] P. Kovanen,et al. Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation , 2010, PloS one.
[173] D. Iliopoulos,et al. NLR family member NLRC5 is a transcriptional regulator of MHC class I genes , 2010, Proceedings of the National Academy of Sciences.
[174] R. Schwarzenbacher,et al. A Role for the Human Nucleotide-binding Domain, Leucine-rich Repeat-containing Family Member NLRC5 in Antiviral Responses* , 2010, The Journal of Biological Chemistry.
[175] Zhijian J. Chen,et al. NLRC5 Negatively Regulates the NF-κB and Type I Interferon Signaling Pathways , 2010, Cell.
[176] K. Moore,et al. NLRP3 inflamasomes are required for atherogenesis and activated by cholesterol crystals that form early in disease , 2010, Nature.
[177] C. Glass,et al. Macrophages, inflammation, and insulin resistance. , 2010, Annual review of physiology.
[178] J. Tschopp,et al. Thioredoxin-interacting protein links oxidative stress to inflammasome activation , 2010, Nature Immunology.
[179] Jeffrey N. Weiser,et al. Recognition of Peptidoglycan from the Microbiota by Nod1 Enhances Systemic Innate Immunity , 2010, Nature Medicine.
[180] J. Friedman,et al. Differential Effects of Cream, Glucose, and Orange Juice on Inflammation, Endotoxin, and the Expression of Toll-Like Receptor-4 and Suppressor of Cytokine Signaling-3 , 2010, Diabetes Care.
[181] P. Rosenstiel,et al. The Nucleotide-Binding Oligomerization Domain-Like Receptor NLRC5 Is Involved in IFN-Dependent Antiviral Immune Responses , 2010, The Journal of Immunology.
[182] L. Almasy,et al. Toward the identification of causal genes in complex diseases: a gene-centric joint test of significance combining genomic and transcriptomic data , 2009, BMC proceedings.
[183] Rob Knight,et al. High-fat diet determines the composition of the murine gut microbiome independently of obesity. , 2009, Gastroenterology.
[184] J. Fernández-Real,et al. Increase in Plasma Endotoxin Concentrations and the Expression of Toll-Like Receptors and Suppressor of Cytokine Signaling-3 in Mononuclear Cells After a High-Fat, High-Carbohydrate Meal , 2009, Diabetes Care.
[185] G. Núñez,et al. Cutting Edge: TNF-α Mediates Sensitization to ATP and Silica via the NLRP3 Inflammasome in the Absence of Microbial Stimulation1 , 2009, The Journal of Immunology.
[186] E. Alnemri,et al. Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression1 , 2009, The Journal of Immunology.
[187] A. Attie,et al. Hypoxia-Inducible Factor 1α Induces Fibrosis and Insulin Resistance in White Adipose Tissue , 2009, Molecular and Cellular Biology.
[188] P. Libby,et al. Obesity, inflammation, and atherosclerosis , 2009, Nature Reviews Cardiology.
[189] Philipp E. Scherer,et al. Metabolic Dysregulation and Adipose Tissue Fibrosis: Role of Collagen VI , 2008, Molecular and Cellular Biology.
[190] Y. Ho,et al. Hypoxia activates NADPH oxidase to increase [ROS]i and [Ca2+]i through the mitochondrial ROS-PKCepsilon signaling axis in pulmonary artery smooth muscle cells. , 2008, Free radical biology & medicine.
[191] S. Girardin,et al. Nucleotide Oligomerization Domains 1 and 2: Regulation of Expression and Function in Preadipocytes1 , 2008, The Journal of Immunology.
[192] K. Rock,et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization , 2008, Nature Immunology.
[193] K. Moore,et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-β , 2008, Nature Immunology.
[194] Richard A. Flavell,et al. The Nalp3 inflammasome is essential for the development of silicosis , 2008, Proceedings of the National Academy of Sciences.
[195] R. Bibiloni,et al. Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in Mice , 2008, Diabetes.
[196] J. Tschopp,et al. Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica , 2008, Science.
[197] L. Fulton,et al. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. , 2008, Cell host & microbe.
[198] Lois J. Maltais,et al. The NLR gene family: a standard nomenclature. , 2008, Immunity.
[199] Y. Sharabi,et al. Differential role and tissue specificity of interleukin-1alpha gene expression in atherogenesis and lipid metabolism. , 2007, Atherosclerosis.
[200] D. Webb,et al. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. , 2007, The American journal of clinical nutrition.
[201] F. Martinon,et al. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration , 2007, Cell Death and Differentiation.
[202] J. Ferrières,et al. Metabolic Endotoxemia Initiates Obesity and Insulin Resistance , 2007, Diabetes.
[203] E. Alnemri,et al. The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation , 2007, Cell Death and Differentiation.
[204] K. Fukase,et al. Differential Modulation of Nods Signaling Pathways by Fatty Acids in Human Colonic Epithelial HCT116 Cells* , 2007, Journal of Biological Chemistry.
[205] Allan Vaag,et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. , 2007, The New England journal of medicine.
[206] Jeffrey I. Gordon,et al. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice , 2007, Proceedings of the National Academy of Sciences.
[207] G. Hotamisligil,et al. Inflammation and metabolic disorders , 2006, Nature.
[208] J. Flier,et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. , 2006, The Journal of clinical investigation.
[209] Y. Yamauchi,et al. Cholesterol sensing, trafficking, and esterification. , 2006, Annual review of cell and developmental biology.
[210] C. Ohlsson,et al. Mature-Onset Obesity in Interleukin-1 Receptor I Knockout Mice , 2006, Diabetes.
[211] Y. Iwakura,et al. Combined interleukin-6 and interleukin-1 deficiency causes obesity in young mice. , 2006, Diabetes.
[212] F. Martinon,et al. Gout-associated uric acid crystals activate the NALP3 inflammasome , 2006, Nature.
[213] V. Dixit,et al. Cryopyrin activates the inflammasome in response to toxins and ATP , 2006, Nature.
[214] G. Dubyak,et al. Inhibitory Effects of Chloride on the Activation of Caspase-1, IL-1β Secretion, and Cytolysis by the P2X7 Receptor1 , 2005, The Journal of Immunology.
[215] Shupei Wang,et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans Published, JLR Papers in Press, September 8, 2005. DOI 10.1194/jlr.M500294-JLR200 , 2005, Journal of Lipid Research.
[216] Morihiro Matsuda,et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. , 2004, The Journal of clinical investigation.
[217] Devjit Tripathy,et al. Differential effects of glucose and alcohol on reactive oxygen species generation and intranuclear nuclear factor-kappaB in mononuclear cells. , 2004, Metabolism: clinical and experimental.
[218] M. Desai,et al. Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.
[219] S. Shoelson,et al. Inflammation and the IKKβ/IκB/NF-κB axis in obesity- and diet-induced insulin resistance , 2003, International Journal of Obesity.
[220] S. Grundy,et al. The metabolic syndrome , 2003, The Lancet.
[221] Y. Iwakura,et al. IL-1 Plays an Important Role in Lipid Metabolism by Regulating Insulin Levels under Physiological Conditions , 2003, The Journal of experimental medicine.
[222] S. Foster,et al. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid , 2003, Nature Immunology.
[223] S. Akira,et al. Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. , 2003, Cardiovascular research.
[224] J. Bertin,et al. Nod1 Detects a Unique Muropeptide from Gram-Negative Bacterial Peptidoglycan , 2003, Science.
[225] J. Ting,et al. Cutting Edge: Monarch-1: A Pyrin/Nucleotide-Binding Domain/Leucine-Rich Repeat Protein That Controls Classical and Nonclassical MHC Class I Genes1 , 2003, The Journal of Immunology.
[226] M. Seishima,et al. Lack of Interleukin-1&bgr; Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[227] M. Chamaillard,et al. Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection* , 2003, The Journal of Biological Chemistry.
[228] S. Foster,et al. Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2 , 2003, The Journal of Biological Chemistry.
[229] T. Rabelink,et al. Postprandial leukocyte increase in healthy subjects. , 2003, Metabolism: clinical and experimental.
[230] F. Martinon,et al. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. , 2002, Molecular cell.
[231] J. Ludwig,et al. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. , 2002, Journal of hepatology.
[232] G. Paolisso,et al. Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. , 2002, Journal of the American College of Cardiology.
[233] A. Tedgui,et al. Interleukin-18/Interleukin-18 Binding Protein Signaling Modulates Atherosclerotic Lesion Development and Stability , 2001, Circulation research.
[234] O. Weichel,et al. Potassium Regulates IL-1β Processing Via Calcium-Independent Phospholipase A21 , 2000, The Journal of Immunology.
[235] H. Kolb,et al. IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis. , 1999, Journal of immunology.
[236] S. Caldwell,et al. Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease , 1999, Hepatology.
[237] J. Born,et al. Systemic immune changes following meal intake in humans. , 1997, The American journal of physiology.
[238] C. Gabel,et al. Human monocyte interleukin-1beta posttranslational processing. Evidence of a volume-regulated response. , 1996, The Journal of biological chemistry.
[239] C. Gabel,et al. Human Monocyte Interleukin-1β Posttranslational Processing , 1996, The Journal of Biological Chemistry.
[240] W. Vogel,et al. Prognosis in nonalcoholic steatohepatitis. , 1995, Gastroenterology.
[241] S. Bhakdi,et al. Potassium‐inhibited processing of IL‐1 beta in human monocytes. , 1995, The EMBO journal.
[242] C. Gabel,et al. Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. , 1994, The Journal of biological chemistry.
[243] B. Mach,et al. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome) , 1993, Cell.
[244] D. Small,et al. George Lyman Duff memorial lecture. Progression and regression of atherosclerotic lesions. Insights from lipid physical biochemistry. , 1988, Arteriosclerosis.
[245] H. Besedovsky,et al. Interleukin 1 affects glucose homeostasis. , 1987, The American journal of physiology.
[246] S. Varshney,et al. Nod1-mediated lipolysis promotes diacylglycerol accumulation and successive inflammation via PKCδ-IRAK axis in adipocytes. , 2019, Biochimica et biophysica acta. Molecular basis of disease.
[247] P. Shridas,et al. High-Density Lipoprotein Inhibits Serum Amyloid A-Mediated Reactive Oxygen Species Generation and NLRP 3 Inflammasome Activation , 2019 .
[248] Aline Haas de Mello,et al. Mitochondrial dysfunction in obesity , 2018, Life sciences.
[249] A. Engin. Adipocyte-Macrophage Cross-Talk in Obesity. , 2017, Advances in experimental medicine and biology.
[250] Cheng Huang,et al. NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis. , 2016, The international journal of biochemistry & cell biology.
[251] D. Philpott,et al. The NOD-Like Receptors , 2016 .
[252] D. Philpott,et al. NOD-like receptors: versatile cytosolic sentinels. , 2015, Physiological reviews.
[253] M. Herieka,et al. High-fat meal induced postprandial inflammation. , 2014, Molecular nutrition & food research.
[254] L. Velloso,et al. Endoplasmic reticulum stress, obesity and diabetes. , 2012, Trends in molecular medicine.
[255] D. Golenbock,et al. Activation of the NLRP 3 Inflammasome , 2012 .
[256] J. Tschopp,et al. The Inflammasomes , 2010, Cell.
[257] Yun‐Min Zheng,et al. Hypoxia activates NADPH oxidase to increase [ROS]i and [Ca2+]i through mitochondrial ROS–PKCε signaling axis in pulmonary artery smooth muscle cells , 2008 .
[258] Y. Le Marchand-Brustel,et al. Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. , 2007, Endocrinology.